• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟与早期多发性硬化症脑萎缩相关,而非 HLA-DRB1*15:01、APOE 或体重指数。

Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.

机构信息

Department of Neurology and Neuroimaging Center (NIC), Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Department of Neurology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany; Department of Neurology, Bern University Hospital, University of Bern, Bern, Switzerland.

出版信息

Mult Scler. 2019 Apr;25(5):661-668. doi: 10.1177/1352458518763541. Epub 2018 Mar 13.

DOI:10.1177/1352458518763541
PMID:29532745
Abstract

BACKGROUND

The course of multiple sclerosis (MS) shows substantial inter-individual variability. The underlying determinants of disease severity likely involve genetic and environmental factors.

OBJECTIVE

The aim of this study was to assess the impact of APOE and HLA polymorphisms as well as smoking and body mass index (BMI) in the very early MS course.

METHODS

Untreated patients ( n = 263) with a recent diagnosis of relapsing-remitting (RR) MS or clinically isolated syndrome underwent standardized magnetic resonance imaging (MRI). Genotyping was performed for single-nucleotide polymorphisms (SNPs) rs3135388 tagging the HLA-DRB1*15:01 haplotype and rs7412 (Ɛ2) and rs429358 (Ɛ4) in APOE. Linear regression analyses were applied based on the three SNPs, smoking and BMI as exposures and MRI surrogate markers for disease severity as outcomes.

RESULTS

Current smoking was associated with reduced gray matter fraction, lower brain parenchymal fraction and increased cerebrospinal fluid fraction in comparison to non-smoking, whereas no effect was observed on white matter fraction. BMI and the SNPs in HLA and APOE were not associated with structural MRI parameters.

CONCLUSIONS

Smoking may have an unfavorable effect on the gray matter fraction as a potential measure of MS severity already in early MS. These findings may impact patients' counseling upon initial diagnosis of MS.

摘要

背景

多发性硬化症(MS)的病程表现出显著的个体间差异。疾病严重程度的潜在决定因素可能涉及遗传和环境因素。

目的

本研究旨在评估 APOE 和 HLA 多态性以及吸烟和体重指数(BMI)在 MS 早期病程中的影响。

方法

对未经治疗的近期诊断为复发缓解型(RR)MS 或临床孤立综合征的患者(n=263)进行了标准化的磁共振成像(MRI)检查。对单核苷酸多态性(SNP)rs3135388 进行基因分型,该 SNP 可标记 HLA-DRB1*15:01 单倍型,以及 APOE 中的 rs7412(Ɛ2)和 rs429358(Ɛ4)。基于三个 SNP、吸烟和 BMI 作为暴露因素,以及 MRI 替代标记物作为疾病严重程度的结果,应用线性回归分析。

结果

与不吸烟相比,当前吸烟与灰质分数降低、脑实质分数降低和脑脊液分数增加有关,而与白质分数无关。BMI 和 HLA 及 APOE 中的 SNP 与结构 MRI 参数无关。

结论

吸烟可能对灰质分数产生不利影响,作为 MS 严重程度的潜在衡量标准,即使在 MS 早期也是如此。这些发现可能会影响患者在 MS 初始诊断时的咨询。

相似文献

1
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.吸烟与早期多发性硬化症脑萎缩相关,而非 HLA-DRB1*15:01、APOE 或体重指数。
Mult Scler. 2019 Apr;25(5):661-668. doi: 10.1177/1352458518763541. Epub 2018 Mar 13.
2
HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.HLA-DRB1*1501、-DQB1*0301、-DQB1*0302、-DQB1*0602和-DQB1*0603等位基因与多发性硬化症患者MRI上更严重的疾病结局相关。
Int Rev Neurobiol. 2007;79:521-35. doi: 10.1016/S0074-7742(07)79023-2.
3
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis.HLA 遗传风险负担与多发性硬化症疾病表型的关联。
JAMA Neurol. 2016 Jul 1;73(7):795-802. doi: 10.1001/jamaneurol.2016.0980.
4
Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.纬度和HLA-DRB1*04:05独立影响日本多发性硬化症的疾病严重程度:一项横断面研究。
J Neuroinflammation. 2016 Sep 6;13(1):239. doi: 10.1186/s12974-016-0695-3.
5
The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.斯洛伐克人群中HLA - DRB1和HLA - DQB1等位基因与多发性硬化症遗传易感性的关联。
Neurol Res. 2015;37(12):1060-7. doi: 10.1080/01616412.2015.1115212. Epub 2016 Jan 8.
6
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy.多发性硬化症与 HLA 基因型:对脑萎缩的可能影响。
Mult Scler. 2019 Jan;25(1):23-30. doi: 10.1177/1352458517739989. Epub 2017 Nov 7.
7
HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.HLA-DRB*1501 与多发性硬化症患者脑灰质病理磁共振成像指标的相关性。
Mult Scler Relat Disord. 2016 May;7:47-52. doi: 10.1016/j.msard.2016.03.003. Epub 2016 Mar 7.
8
HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.HLA(A-B-C 和-DRB1)等位基因与多发性硬化症的脑 MRI 变化:一项纵向研究。
Genes Immun. 2011 Apr;12(3):183-90. doi: 10.1038/gene.2010.58. Epub 2010 Dec 23.
9
Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.多发性硬化症风险基因型与提示预后标志物 CXCL13 的脑脊液水平升高相关。
Mult Scler. 2013 Jun;19(7):863-70. doi: 10.1177/1352458512463482. Epub 2012 Nov 22.
10
Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.载脂蛋白基因型不影响多发性硬化症的严重程度、认知或脑萎缩。
Neurology. 2009 Sep 29;73(13):1018-25. doi: 10.1212/WNL.0b013e3181b9c85e.

引用本文的文献

1
Brain Atrophy and Cognitive Impairment in Primary and Secondary Progressive Multiple Sclerosis Cohort-Similar Progressive MS Phenotype.原发进展型和继发进展型多发性硬化队列中的脑萎缩与认知障碍——相似的进展型多发性硬化表型
Int J Mol Sci. 2025 Sep 2;26(17):8523. doi: 10.3390/ijms26178523.
2
Human leukocyte antigen (HLA) class I and II genetic relationships with brain imaging measures: A systematic review and meta-analysis.人类白细胞抗原(HLA)I类和II类与脑成像测量的遗传关系:一项系统综述和荟萃分析。
Brain Behav Immun. 2025 Aug;128:336-351. doi: 10.1016/j.bbi.2025.04.011. Epub 2025 Apr 11.
3
The Effect of Smoking and Passive Exposure on Multiple Sclerosis and Correlation with IL17 & IL23 Levels.
吸烟及被动接触对多发性硬化症的影响及其与白细胞介素17和白细胞介素23水平的相关性
Noro Psikiyatr Ars. 2025 Feb 7;62(1):54-61. doi: 10.29399/npa.28790. eCollection 2025.
4
The lung-brain axis in multiple sclerosis: Mechanistic insights and future directions.多发性硬化症中的肺-脑轴:机制见解与未来方向
Brain Behav Immun Health. 2024 May 3;38:100787. doi: 10.1016/j.bbih.2024.100787. eCollection 2024 Jul.
5
Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events.多发性硬化症复发表现及结局的性别差异:一项对134次复发事件的回顾性单中心研究。
Ther Adv Neurol Disord. 2024 Mar 26;17:17562864241237853. doi: 10.1177/17562864241237853. eCollection 2024.
6
An optimized method for PCR-based genotyping to detect human APOE polymorphisms.一种基于聚合酶链反应(PCR)基因分型检测人类载脂蛋白E(APOE)多态性的优化方法。
Heliyon. 2023 Oct 19;9(11):e21102. doi: 10.1016/j.heliyon.2023.e21102. eCollection 2023 Nov.
7
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort.多发性硬化症发病时与抑郁情绪相关的因素——对德国全国多发性硬化症队列781例患者的分析
Ther Adv Neurol Disord. 2023 Sep 8;16:17562864231197309. doi: 10.1177/17562864231197309. eCollection 2023.
8
Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients.探讨 HLA 遗传风险负担与多发性硬化症患者丘脑和海马萎缩的关联。
Genes (Basel). 2022 Nov 17;13(11):2136. doi: 10.3390/genes13112136.
9
The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis.吸烟对复发缓解型多发性硬化患者长期灰质萎缩和临床残疾的影响。
Neurol Neuroimmunol Neuroinflamm. 2022 Jun 23;9(5). doi: 10.1212/NXI.0000000000200008. Print 2022 Sep.
10
Environmental and genetic risk factors for MS: an integrated review.MS 的环境和遗传风险因素:综合述评。
Ann Clin Transl Neurol. 2019 Sep;6(9):1905-1922. doi: 10.1002/acn3.50862. Epub 2019 Aug 7.